Most recent articles by:

Editorial Team

- Advertisement -

China forces insulin price cuts resulting in pullback for global pharma players

Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by China’s volume-based procurement (VBP) program....

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks to buy Vifor Pharma in a deal that is valued at $7B, or A$10B. Vifor...

Sanofi to acquire Origimm Biotechnology in a bid to expand vaccine pipeline

Sanofi will acquire Origimm Biotechnology as per an agreement signed by the two healthcare companies. The deal is expected to be finalized...

Moberg Pharma joins hands with Allderma to market nail fungus product in Scandinavia

Moberg pharma joins hands with Allderma to enter the market with a new nail fungus product named MOB-015. Moberg...

Mekonos closes $25M funding round for cell therapy platform

Mekonos closes funding of $25M in a series a round as it develops the future of cell therapies on a chip. The...

U.S. to buy additional $1B of Merck’s Covid-19 drug

In the latest Merck’s COVID-19 news, it was reported that President Biden’s government has plans to place an order for another batch...

Bayer Raises Enthusiasm about Kerendia Heart and Kidney Disease Drug after SGLT2 Patients see Benefits

It was previously thought that the heart and kidney disease drug Kerendia, was in competition with SGLT2 diabetes medications. However, recent data...

Merck acquires Acceleron Pharma for $11.5B to expand cardiovascular pipeline

To aid the growth of its expanding cardiovascular treatments pipeline, Merck is striking an acquisition deal worth $11.5B with the Acceleron Pharma....

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC
- Advertisement -